New Atlas1d
Alzheimer’s drug trial raises concerns for accelerating cognitive decline
While growing evidence suggests that there’s a link between blood iron levels and the development of Alzheimer’s disease, new ...
Anavex, Cassava Sciences, Panax Ginseng, And The Long-Term Treatment Of Alzheimer's Disease
Panax ginseng shows highest effectiveness in treating Alzheimer's. Learn more about AVXL's blarcamesine and SAVA's simufilam ...
Opinion: Too many older Americans are getting tested for Alzheimer’s
An 80-something patient came in for an annual visit recently and was worried that recent memory lapses might be symptoms of ...
MM&M13d
AbbVie takes bet on new Alzheimer’s drug in $1.4 billion acquisition of Aliada Therapeutics
The purchase is the latest in a slew of efforts to invest in its neuroscience portfolio as Humira faces generic competition.
Gradual dosing of Lilly Alzheimer's drug cuts brain-swelling risk, study finds
Starting on a more gradual dosing schedule of Eli Lilly's Alzheimer's drug Kisunla cut the percentage of patients ...
STAT12d
Eli Lilly says modified dosing of its Alzheimer’s drug may be safer
A change in the dosing regimen of Eli Lilly’s Alzheimer’s drug Kisunla resulted in a lower rate of brain swelling among ...
Alzheimer’s treatment donanemab is not a ‘miracle drug’ – not providing it on the NHS is the right choice
There is a lot of outrage that the new Alzheimer’s drug donanemab is being refused on the NHS. But there are good reasons for ...
Study highlights challenges of reducing risky drugs in Alzheimer's patients
Can large national health plans make an impact in reducing prescribing of high-risk medications to people with Alzheimer's ...
Alzheimer's: Common Drug May Help Fight Off Dementia
A drug that is commonly used to treat eye diseases may soon be used to protect against dementia, new research suggests. The drug may also show promise in the treatment of other neurodegenerative ...
pharmaphorum3d
Eisai dials back forecasts for Alzheimer's drug Leqembi
Longer-term, Eisai and Biogen are hoping for further evidence to support Leqembi from the phase 3 AHEAD 3-45 trial, which ...
Hosted on MSN5d
Weekend Warriors and Dementia; Iron Chelation and Alzheimer's; Neuro Drug Costs Rise
(JAMA Neurology) The investigational anti-tau antibody bepranemab missed its primary cognitive endpoint in a phase II trial ...
Medical Xpress13d
Alzheimer's drug approved in the UK, but it won't be available on the NHS—here's why
The UK's drugs regulator—the MHRA—has approved the Alzheimer's drug donanemab, but it won't be available on the NHS. The National Institute for Health and Care Excellence (Nice), which ...